Quality of care in bronchiectasis using the European Respiratory Society Guidelines as a reference standard- data from the EMBARC registry

P. Goeminne (Nikolaas, Belgium), P. Burgel (Paris, France), M. Shteinberg (Haifa, Israel), E. Polverino (Barcelona, Spain), C. Haworth (Cambridge, United Kingdom), M. Loebinger (London, United Kingdom), A. Torres (Barcelona, Spain), O. Sibila (Barcelona, Spain), F. Blasi (Milan, Italy), T. Welte (Hannover, Germany), A. Desoyza (Newcastle, United Kingdom), M. Vendrell (Girona, Spain), F. Ringshausen (Hannover, United Kingdom), A. Shoemark (Dundee (Angus), United Kingdom), A. Hill (Edinburgh, United Kingdom), M. Crichton (Dundee (Angus), United Kingdom), S. Elborn (Belfast, United Kingdom), W. Boersma (Alkmaar, Netherlands), R. Wilson (London, United Kingdom), K. Dimakou (Athens, Greece), J. Chalmers (Dundee (Angus), United Kingdom), S. Aliberti (Milan, Italy)

Source: Virtual Congress 2021 – Respiratory infections and bronchiectasis outcomes
Session: Respiratory infections and bronchiectasis outcomes
Session type: Oral Presentation
Number: 2854

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Goeminne (Nikolaas, Belgium), P. Burgel (Paris, France), M. Shteinberg (Haifa, Israel), E. Polverino (Barcelona, Spain), C. Haworth (Cambridge, United Kingdom), M. Loebinger (London, United Kingdom), A. Torres (Barcelona, Spain), O. Sibila (Barcelona, Spain), F. Blasi (Milan, Italy), T. Welte (Hannover, Germany), A. Desoyza (Newcastle, United Kingdom), M. Vendrell (Girona, Spain), F. Ringshausen (Hannover, United Kingdom), A. Shoemark (Dundee (Angus), United Kingdom), A. Hill (Edinburgh, United Kingdom), M. Crichton (Dundee (Angus), United Kingdom), S. Elborn (Belfast, United Kingdom), W. Boersma (Alkmaar, Netherlands), R. Wilson (London, United Kingdom), K. Dimakou (Athens, Greece), J. Chalmers (Dundee (Angus), United Kingdom), S. Aliberti (Milan, Italy). Quality of care in bronchiectasis using the European Respiratory Society Guidelines as a reference standard- data from the EMBARC registry. 2854

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
European Respiratory Society guidelines for the management of adult bronchiectasis
Source: Eur Respir J, 50 (3) 1700629; 10.1183/13993003.00629-2017
Year: 2017



European Respiratory Society guidelines for the management of adult bronchiectasis
Source: Guideline 2017
Year: 2017

Stratification of COPD in primary health care: use of Spanish Society of Pulmonology (SEPAR) and Spanish Society of Community Health Medicine (SEMFYC) guidelines
Source: Eur Respir J 2005; 26: Suppl. 49, 544s
Year: 2005

Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline - ERS pocket guideline
Source: Guideline 2017
Year: 2017

Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline
Source: Eur Respir J , 49 (3) 1600791; DOI: 10.1183/13993003.00791-2016
Year: 2017



Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline
Source: Guideline 2017
Year: 2017


Treatment of sarcoidosis: clinical guidelines of the Russian Respiratory Society
Source: Virtual Congress 2021 – Russian programme 2021
Year: 2021


European Respiratory Society Guidelines on the use of nebulizers
Source: Guideline 2001
Year: 2001

Management of severe asthma: a European Respiratory Society/American Thoracic Society guideline
Source: Guideline 2020
Year: 2020

Management of severe asthma: a European Respiratory Society/American Thoracic Society guideline
Source: Eur Respir J, 55 (1) 1900588; 10.1183/13993003.00588-2019
Year: 2020



European Respiratory Society living guidelines on the management of hospitalized patients with COVID-19
Source: Virtual Congress 2021 – Precision medicine in respiratory infections
Year: 2021


Prevention of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline
Source: Eur Respir J, 50 (3) 1602265; 10.1183/13993003.02265-2016
Year: 2017



Prevention of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline
Source: Guideline 2017
Year: 2017

European Respiratory Society Guidelines on the use of nebulizers: Guidelines prepared by a European Respiratory Society Task Force on the use of nebulizers
Source: Eur Respir J 2001; 18: 228-242
Year: 2001


Nutritional assessment and therapy in COPD: a European Respiratory Society statement
Source: Eur Respir J 2014; 44: 1504-1520
Year: 2014



Nutritional assessment and therapy in COPD: a European Respiratory Society statement
Source: Guideline 2014
Year: 2014

European Respiratory Society guidelines for the management of children and adolescents with bronchiectasis
Source: Eur Respir J, 58 (2) 2002990; 10.1183/13993003.02990-2020
Year: 2021



European Respiratory Society guidelines for the management of children and adolescents with bronchiectasis
Source: Guideline 2021
Year: 2021



European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis
Source: Eur Respir J 2010; 35: 14-26
Year: 2010


An official American Thoracic Society and European Respiratory Society policy statement: disparities in respiratory health
Source: Eur Respir J 2013; 42: 906-915
Year: 2013